-
公开(公告)号:US20230149540A1
公开(公告)日:2023-05-18
申请号:US17916942
申请日:2021-04-06
CPC分类号: A61K39/39 , A61K39/00119 , A61K39/3955 , A61K38/1774 , C07K16/2803 , A61P35/00 , A61K2039/55555 , A61K2039/55516
摘要: Compositions and methods are provided relating to vaccine formulations comprising (i) an agent that specifically binds to CD244; (ii) an effective dose of an antigen; and (iii) an adjuvant, which adjuvant can be, without limitation, an activator of innate-like T cells.